Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
1,892
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

How urban versus rural population relates to COVID-19 booster vaccine hesitancy: A propensity score matching design study

Yudong Miaoa Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaCorrespondence[email protected]
View further author information
,
Junwen Baia Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Zhanlei Shena Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Yi Lia Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Wanliang Zhanga Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Dongfang Zhua Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China;b Institute for Hospital Management of Henan Province, Henan, ChinaView further author information
,
Ruizhe Rena Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Jingbao Zhanga Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Dan Guoa Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China;c Department of Neurology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Clifford Silver Tarimoa Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China;d Department of Science and Laboratory Technology, Dar es Salaam Institute of Technology, Dar es Salaam, TanzaniaView further author information
,
Wenyong Donge Department of Hypertension, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Rongmei Liuf Henan Key Laboratory for Health Management of Chronic Diseases, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Qiuping Zhaof Henan Key Laboratory for Health Management of Chronic Diseases, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Jianping Hug Henan Engineering technology Research Center for Health Big Data Governance, Henan Medical Communication and Project Forward Center, Zhengzhou, Henan, ChinaView further author information
,
Miaojun Lig Henan Engineering technology Research Center for Health Big Data Governance, Henan Medical Communication and Project Forward Center, Zhengzhou, Henan, ChinaView further author information
&
Wei Weih Department of Medical Imaging, Henan Provincial People’s Hospital & the People’s Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2297490 | Received 29 Aug 2023, Accepted 18 Dec 2023, Published online: 12 Jan 2024

References

  • Burki T. WHO ends the COVID-19 public health emergency. Lancet Respir Med. 2023;11(7):SS2213–11. doi:10.1016/S2213-2600(23)00217-5.
  • Debellut F, Clark A, Pecenka C, Tate J, Baral R, Sanderson C, Parashar U, Atherly D. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. Lancet Glob Health. 2021;9(7):e942–56. doi:10.1016/S2214-109X(21)00167-4.
  • Jentsch PC, Anand M, Bauch CT. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study. Lancet Infect Dis. 2021;21(8):1097–106. doi:10.1016/S1473-3099(21)00057-8.
  • Spitzer A, Angel Y, Marudi O, Zeltser D, Saiag E, Goldshmidt H, Goldiner I, Stark M, Halutz O, Gamzu R, et al. Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel. JAMA. 2022;327(4):341–9. doi:10.1001/jama.2021.23641.
  • Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, et al. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar. N Engl J Med. 2022;386(19):1804–16. doi:10.1056/NEJMoa2200797.
  • Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–81. doi:10.1016/S0140-6736(21)00234-8.
  • Nguyen V-T, Huang Y, Huang M, Tsai J. Factors related to COVID-19 vaccine hesitancy among middle-income and low-income adults in the USA. J Epidemiol Community Health. 2023;77(5):328–35. doi:10.1136/jech-2021-218535.
  • MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4. doi:10.1016/j.vaccine.2015.04.036.
  • Dubé È, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Annu Rev Public Health. 2021;42(1):175–91. doi:10.1146/annurev-publhealth-090419-102240.
  • Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. doi:10.1038/s41591-021-01454-y.
  • Okubo R, Yoshioka T, Ohfuji S, Matsuo T, Tabuchi T. COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines (Basel). 2021;9(6):662. doi:10.3390/vaccines9060662.
  • Montalti M, Di Valerio Z, Rallo F, Squillace L, Costantino C, Tomasello F, Mauro GL, Stillo M, Perrone P, Resi D, et al. Attitudes toward the SARS-CoV-2 and influenza vaccination in the metropolitan cities of Bologna and Palermo, Italy. Vaccines (Basel). 2021;9(10):1200. doi:10.3390/vaccines9101200.
  • Reno C, Maietti E, Fantini MP, Savoia E, Manzoli L, Montalti M, Gori D. Enhancing COVID-19 vaccines acceptance: results from a survey on vaccine hesitancy in Northern Italy. Vaccines (Basel). 2021;9(4):378. doi:10.3390/vaccines9040378.
  • Quinn SC, Andrasik MP. Addressing vaccine hesitancy in BIPOC communities — toward trustworthiness, partnership, and reciprocity. N Engl J Med. 2021;385(2):97–100. doi:10.1056/NEJMp2103104.
  • Simas C, Larson HJ. Overcoming vaccine hesitancy in low-income and middle-income regions. Nat Rev Dis Primers. 2021;7(1):41. doi:10.1038/s41572-021-00279-w.
  • Ma C, Song Z, Zong Q. Urban-rural inequality of opportunity in health care: evidence from China. Int J Environ Res Public Health. 2021;18(15):7792. doi:10.3390/ijerph18157792.
  • Anand S, Fan VY, Zhang J, Zhang L, Ke Y, Dong Z, Chen LC. China’s human resources for health: quantity, quality, and distribution. The Lancet. 2008;372(9651):1774–81. doi:10.1016/S0140-6736(08)61363-X.
  • National Health Commission of China. China Health statistics yearbook 2022. China Union Medical University Press.
  • Wu J, Li Q, Silver Tarimo C, Wang M, Gu J, Wei W, Ma M, Zhao L, Mu Z, Miao Y. COVID-19 vaccine hesitancy among Chinese population: a large-scale national study. Front Immunol. 2021;12:781161. doi:10.3389/fimmu.2021.781161.
  • Xia S, Wang L, Zhu Y, Lu L, Jiang S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 omicron sublineages. Sig Transduct Target Ther. 2022;7(1):241. doi:10.1038/s41392-022-01105-9.
  • Wang W, Wu Q, Yang J, Dong K, Chen X, Bai X, Chen X, Chen Z, Viboud C, Ajelli M, et al. Global, regional, and national estimates of target population sizes for COVID-19 vaccination: descriptive study. BMJ. 2020;371:m4704. doi:10.1136/bmj.m4704.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225. doi:10.1038/s41591-020-1124-9.
  • Bartsch YC, Tong X, Kang J, Avendaño MJ, Serrano EF, García-Salum T, Pardo-Roa C, Riquelme A, Cai Y, Renzi I, et al. Omicron variant spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines. Sci Transl Med. 2022;14(642):eabn9243. doi:10.1126/scitranslmed.abn9243.
  • Ouyang H, Ma X, Wu X. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic. Human Vaccines & Immunotherapeutics [Internet]; 2022 [accessed 2023 Aug 28]. p.18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920136/.
  • Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci USA. 2021;118(10):e2021726118. doi:10.1073/pnas.2021726118.
  • Dubé E, MacDonald NE. COVID-19 vaccine hesitancy. Nat Rev Nephrol. 2022;18(7):409–10. doi:10.1038/s41581-022-00571-2.
  • Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines (Basel). 2021;9(1):48. doi:10.3390/vaccines9010048.
  • Acar-Burkay S, Cristian D-C. Cognitive underpinnings of COVID-19 vaccine hesitancy. Social Sci Med. 2022;301:114911. doi:10.1016/j.socscimed.2022.114911.
  • Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, et al. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet. 2021;398(10317):2186–92. doi:10.1016/S0140-6736(21)02507-1.
  • Du F, Chantler T, Francis MR, Sun FY, Zhang X, Han K, Rodewald L, Yu H, Tu S, Larson H, et al. The determinants of vaccine hesitancy in China: a cross-sectional study following the changchun changsheng vaccine incident. Vaccine. 2020;38(47):7464–71. doi:10.1016/j.vaccine.2020.09.075.
  • Bokemper SE, Huber GA, Gerber AS, James EK, Omer SB. Timing of COVID-19 vaccine approval and endorsement by public figures. Vaccine. 2021;39(5):825–9. doi:10.1016/j.vaccine.2020.12.048.
  • Hunter CM, Chou W-Y, Webb Hooper M. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives. Transl Behav Med. 2021;11(7):1354–8. doi:10.1093/tbm/ibab067.
  • Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine. 2011;29(38):6472–84. doi:10.1016/j.vaccine.2011.06.107.
  • Alhaffar M, Douedari Y, Howard N. “In general people aren’t excited about the vaccine…”: frontline perspectives on COVID-19 vaccine hesitancy across Syria. Hum Vaccin Immunother. 2023;19(2):2235239. doi:10.1080/21645515.2023.2235239.
  • Ouyang H, Ma X, Wu X. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic. Hum Vaccin Immunother. 2022;18(1):2013694. doi:10.1080/21645515.2021.2013694.
  • Wu J, Ma M, Li Q, Guo X, Tarimo CS, Jia S, Zhou X, Wang M, Gu J, Miao Y, et al. Dynamic trends and underlying factors of COVID-19 vaccine booster hesitancy in adults: cross-sectional observational study. JMIR Public Health Surveill. 2023;9:e44822. doi:10.2196/44822.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.